Anna Hultberg

Title: The Innovative Contributions of Anna Hultberg

Introduction

Anna Hultberg is a prominent inventor based in Sint-Martens-Latem, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies and chimeric polypeptides. With a total of eight patents to her name, Hultberg's work has the potential to impact various medical applications.

Latest Patents

Among her latest patents is the invention of anti c-Met antibodies. This invention relates to antibodies that specifically bind to the human c-Met receptor protein, acting as strict antagonists of hepatocyte growth factor (HGF)-mediated activation of the c-Met receptor. Additionally, these antibodies inhibit HGF-independent activation of the human c-Met protein. Another notable patent involves chimeric human-llama antigens and methods of use. This invention provides chimeric, camelid-human polypeptides that comprise a first antigenic polypeptide portion derived from a camelid and a second antigenic polypeptide portion that is a human homolog. These chimeric polypeptides are useful for epitope mapping and generating antibodies that bind to specific regions of human antigens.

Career Highlights

Hultberg has worked with several notable companies in the biotechnology sector, including Argenx N.V. and Ablynx N.V. Her experience in these organizations has allowed her to develop her innovative ideas and contribute to significant advancements in her field.

Collaborations

Some of her coworkers include Natalie De Jonge and Michael Saunders. Their collaboration has likely fostered a creative environment that encourages innovation and the development of groundbreaking technologies.

Conclusion

Anna Hultberg's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical science and therapeutic applications.